Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Pharmacokinetics and disposition in the rat of a DNA intercalator 502U83.

Patel DK, Lewis RP, Hinton ML, Schroeder DH, Shockcor JP, Johnson RL, Sigel CW.

Drug Metab Dispos. 1993 Jan-Feb;21(1):62-70.

PMID:
8095228
2.

Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.

Vincent SH, Painter SK, Krieter PA, Colletti AE, Lyszack E, Rosegay A, Dean D, Luffer-Atlas D, Miller RR, Cioffe C, Chiu SH.

Drug Metab Dispos. 1996 Dec;24(12):1369-77.

PMID:
8971144
3.

Disposition, metabolism, and excretion of the anticancer agent crisnatol in the rat.

Patel DK, Woolley JL Jr, Shcokcor JP, Johnson RL, Taylor LC, Sigel CW.

Drug Metab Dispos. 1991 Mar-Apr;19(2):491-7.

PMID:
1676660
4.
5.

Disposition and metabolism of finasteride in dogs.

Carlin JR, Christofalo P, Arison BH, Ellsworth RE, Rosegay A, Miller RR, Chiu SH, VandenHeuvel WJ.

Drug Metab Dispos. 1997 Jan;25(1):100-9.

6.

Evaluation of metabolism and disposition of GDC-0152 in rats using 14C labeling strategy at two different positions: a novel formation of hippuric acid from 4-phenyl-5-amino-1,2,3-thiadiazole.

Yue Q, Mulder T, Rudewicz PJ, Solon E, Budha N, Ware JA, Lyssikatos J, Hop CE, Wong H, Khojasteh SC.

Drug Metab Dispos. 2013 Feb;41(2):508-17. doi: 10.1124/dmd.112.047019. Epub 2012 Dec 4.

7.

Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.

Paulson SK, Zhang JY, Breau AP, Hribar JD, Liu NW, Jessen SM, Lawal YM, Cogburn JN, Gresk CJ, Markos CS, Maziasz TJ, Schoenhard GL, Burton EG.

Drug Metab Dispos. 2000 May;28(5):514-21.

9.

Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.

Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.

Arzneimittelforschung. 1998 Oct;48(10):995-1006.

PMID:
9825117
10.

Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.

Schoenig GP, Hartnagel RE Jr, Osimitz TG, Llanso S.

Drug Metab Dispos. 1996 Feb;24(2):156-63.

PMID:
8742226
11.

Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.

Leung KH, Cohn DA, Miller RR, Doss GA, Stearns RA, Simpson RE, Feeney WP, Chiu SH.

Drug Metab Dispos. 1996 Jul;24(7):753-60.

PMID:
8818572
12.

Disposition of [14C]velnacrine maleate in rats, dogs, and humans.

Turcan RG, Hillbeck D, Hartley TE, Gilbert PJ, Coe RA, Troke JA, Vose CW.

Drug Metab Dispos. 1993 Nov-Dec;21(6):1037-47.

PMID:
7905382
13.

HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.

Lenz EM, D'Souza RA, Jordan AC, King CD, Smith SM, Phillips PJ, McCormick AD, Roberts DW.

J Pharm Biomed Anal. 2007 Feb 19;43(3):1065-77. Epub 2006 Oct 9.

PMID:
17030109
14.

Tissue distribution and excretion of 14C-labelled cinnamic aldehyde following single and multiple oral administration in male Fischer 344 rats.

Sapienza PP, Ikeda GJ, Warr PI, Plummer SL, Dailey RE, Lin CS.

Food Chem Toxicol. 1993 Apr;31(4):253-61.

PMID:
8477915
16.
17.

Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.

Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.

Arzneimittelforschung. 1993 Oct;43(10):1084-94.

PMID:
8267675
18.
19.

Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.

Emary WB, Toren PC, Mathews B, Huh K.

Drug Metab Dispos. 1998 Aug;26(8):725-31.

20.

Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration.

Bollard M, Caldwell J, Taylor GW, Strolin-Benedetti M, Semeraro C.

Xenobiotica. 2000 Oct;30(10):983-91.

PMID:
11315106

Supplemental Content

Support Center